Lv1
20 积分 2024-06-05 加入
Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial
4小时前
已完结
Impact of personalized response-directed surgery and adjuvant therapy on survival after neoadjuvant immunotherapy in stage III melanoma: Comparison of 3-year data from PRADO and OpACIN-neo
9小时前
已完结
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma
1天前
已完结
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma
7天前
已完结
NeoPlus: A phase II study of neoadjuvant lenvatinib and pembrolizumab in resectable mucosal melanoma
10天前
已关闭
激光美容相关常见疾病诊疗指南(2024版)
1个月前
已完结
Mechanisms of immune activation and regulation: lessons from melanoma
4个月前
已完结
The journey from melanocytes to melanoma
4个月前
已完结
Cutaneous melanoma
4个月前
已完结
Melanoma: a global perspective
4个月前
已完结
皖公网安备34019202002308
